Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 9BAYER HLTHCARE
02 30EXELTIS USA INC
03 7MAYNE PHARMA
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22574
Patent Use Code : U-1
Delist Requested :
Patent Use Description : PREVENTION OF PREGNANC...
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22574
Patent Use Code : U-3572
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-1
Delist Requested :
Patent Use Description : PREVENTION OF PREGNANC...
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-3572
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-3573
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-07-17
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 11617751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code : U-3574
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-17
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-02-08
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 8617597
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22574
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-02-08
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2031-10-22
US Patent Number : 8906890
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21355
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-10-22
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2030-02-08
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US Patent Number : 8617597
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22532
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-02-08
